Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04903353

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Conditions: Weight Gain, Autism Spectrum Disorder, Medication Side Effect

Sex: All

Ages: N/A – 17 Years

Healthy volunteers: Yes

Phase: PHASE4

Enrollment: 30

Sponsor: Vanderbilt University Medical Center

Location: Division of Developmental Medicine Nashville Tennessee

Summary

This study aims to compare two FDA approved medications (aripiprazole and risperidone) for the treatment of behavioral dysregulation in children with autism spectrum disorders. This trial, done in the context of routine clinical care, will seek to evaluate whether aripiprazole or risperidone is associated with more weight gain in children.

Eligibility Criteria

Inclusion Criteria: * age 17 years and younger * diagnosed with autism * have behavior problems * seen in Vanderbilt clinic * naïve to atypical antipsychotics Exclusion Criteria: * 18 years or older * history of atypical antipsychotic use * not diagnosed with autism

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04903353). StuddyBuddy aggregates publicly available trial information.